Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced M2-polarization of macrophages

Cellular and Molecular Biology

Volumn 60, Issue 3, 2014, Pages 10-15

  Dubey, P ^b   Shrivastava, R ^a,d   Tripathi, C ^a,d   Jain, N K ^a   Tewari, B N ^b   Lone, M U D ^a   Baghel, K S ^a   Kumar, V ^b   Misra, S ^b   Bhadauria, Smrati ^a   Bhatt, M L B ^c  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c Dr RML Institute of Medical Sciences Lucknow   (India)

^d ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH   (India)

Author keywords

COX 2; Flunixin meglumine; Hypoxia; M2 polarization; Pro angiogenic

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN; CD206 ANTIGEN; CYCLOOXYGENASE 2; FLUNIXIN MEGLUMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; CLONIXIN; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PTGS2 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CHORIOALLANTOIC MEMBRANE ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIC TUMOR; IMMUNOCYTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR REPROGRAMMING; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BREAST NEOPLASMS; CELL HYPOXIA; CHICK EMBRYO; CHORIOALLANTOIS; CYTOLOGY; DRUG EFFECTS; FEMALE; MACROPHAGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CLONIXIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919627402     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2014.60.3.2     Document Type: Article

References (29)

1. Robinson, B.D., Gabriel, L., Sica, A., Yi-Fang Liu, T.E., Rohan, F., Gertler, B., John , S.C., and Joan, G.J. Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination. Clin Cancer Res. 2009, 15(7): 2433-2441. doi: 10.1158/1078-0432.CCR-08-2179
2. Sica, A., Schioppa, T., Mantovani, A., and Altadena, P. Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: potential targets of anti-cancer therapy. Eur. J. Cancer. 2006, 42:717-727.
3. Mueller, M.M., and Fusing, N.E. Friends or foes - bipolar effects of the tumor stoma in cancer. Nat. Rev. Cancer. 2004, 4:839-849.
4. Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K.E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., and Tabar, V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010, 468:829-833. doi: 10.1038/nature09624
5. Welford, A.F, Biziato, D., Coffelt, S.B., Nucera, S., Fisher, M., Pucci, F., Di, S.C., Naldini, L., De, P.M., Tozer, G.M., and Lewis, C.E. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J. Clin. Invest. 2011, 121: 1969-1973. doi: 10.1172/JCI44562
6. Gordon, S., and Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5: 953-964. doi: 10.1038/nri1733
7. Lawrence, T., Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011, 11(11):750-61. doi: 10.1038/ nri3088
8. Gordon, G.J., Rockwell, G.N., Jensen, R.V., Rheinwald, J.G., Glickman, J.N., Aronson, J.P., Pottorf, B.J., Nitz, M.D., Richards, W.G., Sugarbaker, D.J. et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am. J. Pathol. 2005, 166:1827-1840. doi: 10.1016/S0002-9440(10)62492-3
9. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686. doi: 10.1016/j.it.2004.09.015
10. Biswas, S.K., Sica, A., and Lewis, C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 2008, 180:2011-2017. doi: 10.4049/jimmunol.180.4.2011
11. Ohno, S., Ohno, Y., Suzuki, N., Kamei, T., Koike, K., Inagawa, H., Kohchi, C., Soma, G., and Inoue, M. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 2004, 24:3335-3342.
12. Leek, R.D., Lewis, C.E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A.L., Association of macrophage infiltration with an giogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996, 56:4625-4629.
13. Leek, R.D., Landers, R.J., Harris, A.L., and Lewis, C.E. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer. 1999, 79:991-995. doi: 10.1038/sj.bjc.6690158
14. Burton, J.L., Oakley, N., and Anderson, J.B., Recent advances in the histopathology and molecular biology of prostate cancer. BJU. Int. 2000, 85:87-94. doi: 10.1046/j.1464-410x.2000.00422.x
15. Negus, R.P.M., Stamp, G.W.H., Hadley, J., Balkwill, F.R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol. 1997,150:1723-1734
16. Thun, M.J., Henley, S.J., Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002, 94: 252-266. doi: 10.1093/jnci/94.4.252
17. Dannenberg, A.J., Altorki, N.K., Boyle, J.O., Dang, C., Howe, L.R., et al. Cyclooxygenase2: a pharmacological target for the prevention of cancer. Lancet Oncol. 2001, 2: 544-551.
18. Wang, D., Mann, J.R., DuBois, R.N. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology. 2005, 128: 1445-1461. doi: 10.1053/j.gastro.2004.09.080
19. Daigneault, M., Preston, J.A., Marriott, H.M., Whyte, M.K., and Dockrell, D.H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010, 5:e8668. doi: 10.1371/journal.pone.0008668
20. Lowry, O.H., Nira, J.R.A., Lewis. F., and Rose, J. R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193: 265-275.
21. Tripathi, C., Tewari, B.N., Kanchan, R.K., Baghel, K.S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M.L., Bhadauria, S. Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget. 2014, 5(14):5350-68.
22. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem. 1992, 267:10931-10934.
23. Helmlinger, G., Netti, P.A., Lichtenbeld, H.C., Melder, R.J., Jain, R.K., Solid stress inhibits the growth of multispheroid tumors. Nature Biotechnology. 1997, 15:778-783.
24. Park, J.E., Tan, H.S., Datta, A., Lai, R.C, Zhang, H., Meng, W., Lim, S.K, Sze ,S. K. Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes. Mol Cell Proteomics. 2010. 9(6): 1085-1099. doi: 10.1074/mcp.M900381-MCP200
25. De, P.M, and Lewis, C.E. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013, 23:277-286.
26. Lewis, C.E, and Pollard, J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612. doi: 10.1158/0008-5472.CAN-05-4005
27. Vane, J. R., Bakhle, Y. S. & Botting, R. M. Annu. Rev. Pharmacol. Toxicol. 1998, 38:97-120
28. Na, Y.R., Yoon, Y.N., Son. D.I., Seok S.H., Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS ONE. 2013, 8(5): e63451. doi:10.1371/journal.pone.0063451
29. Radi, Z.A. Pathphysiology of cyclooxygenase Inhibition in Animal Models. Toxicologic Pathology.2009,37:34-46. doi: 10.1177/0192623308329474